Fulvestrant: A Further Treatment Option for Patients With Metastatic Uterine Cancer?

Oncology Research and Treatment - Switzerland
doi 10.1159/000096541
Full Text
Abstract

Available in full text

Date
Authors
Publisher

S. Karger AG

Related search

Fulvestrant ('Faslodex')--A New Treatment Option for Patients Progressing on Prior Endocrine Therapy

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2002English

Fulvestrant Treatment Is Associated With Cholesterol Plasma Level Reduction in Hormone Receptor-Positive Metastatic Breast Cancer Patients

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2009English

Developing a Prediction Model for Benefit From Fulvestrant in Heavily Pretreated Metastatic Breast Cancer Patients

Breast Cancer Research
Cancer ResearchOncology
2009English

Ixabepilone: A New Treatment Option for the Management of Taxane-Resistant Metastatic Breast Cancer

Cancer Management and Research
Oncology
2009English

Further Evidence That Onabotulinum Toxin Is a Viable Treatment Option for Pediatric Chronic Migraine Patients

Cureus
2019English

A Case of Metastatic Uterine Cancer From Breast Cancer

Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons)
2002English

New Option for the Initial Management of Metastatic Pancreatic Cancer?

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2014English

Vinflunine Treatment in Patients With Metastatic Urothelial Cancer: A Nordic Retrospective Multicenter Analysis

Oncology Letters
Cancer ResearchOncology
2016English

Is Fertility Sparing Surgery a Treatment Option for Premenopausal Patients With Dysgerminoma?

Bratislava Medical Journal
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy